BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3785797)

  • 1. Prophylactic topical 5-fluorouracil following treatment of human papillomavirus-associated lesions of the vulva and vagina.
    Krebs HB
    Obstet Gynecol; 1986 Dec; 68(6):837-41. PubMed ID: 3785797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus-associated lesions of the vagina and cervix. Treatment with a laser and topical 5-fluorouracil.
    Brodman M; Dottino P; Friedman F; Heller D; Bleiweiss I; Sperling R
    J Reprod Med; 1992 May; 37(5):453-6. PubMed ID: 1324311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical 5-fluorouracil in the treatment of intraepithelial neoplasia of the vagina.
    Ballon SC; Roberts JA; Lagasse LD
    Obstet Gynecol; 1979 Aug; 54(2):163-6. PubMed ID: 460749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic ulcerations following topical therapy with 5-fluorouracil for vaginal human papillomavirus-associated lesions.
    Krebs HB; Helmkamp BF
    Obstet Gynecol; 1991 Aug; 78(2):205-8. PubMed ID: 1648696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of carcinoma in situ of the vulva with topical 5-fluorouracil.
    Lifshitz S; Roberts JA
    Obstet Gynecol; 1980 Aug; 56(2):242-4. PubMed ID: 7393516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical 5-FU reduces CIN recurrence.
    Newsline People AIDS Coalit N Y; 1999; ():31. PubMed ID: 11367342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superficial laser vulvectomy. IV. Extended laser vaporization and adjunctive 5-fluorouracil therapy of human papillomavirus-associated vulvar disease.
    Reid R; Greenberg MD; Lörincz AT; Daoud Y; Pizzuti D; Stoler M
    Obstet Gynecol; 1990 Sep; 76(3 Pt 1):439-48. PubMed ID: 2166264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical 5-fluorouracil treatment of transformation zone intraepithelial neoplasia of cervix and vagina.
    Pride GL; Chuprevich TW
    Obstet Gynecol; 1982 Oct; 60(4):467-72. PubMed ID: 7121934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of vaginal condylomata acuminata by weekly topical application of 5-fluorouracil.
    Krebs HB
    Obstet Gynecol; 1987 Jul; 70(1):68-71. PubMed ID: 3601270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-fluorouracil topical treatment of in situ vulvar cancer. A preliminary report.
    Krupp PJ; Bohm JW
    Obstet Gynecol; 1978 Jun; 51(6):702-6. PubMed ID: 662250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisplatin, 5-fluorouracil, and ifosfamide in the treatment of recurrent or advanced cervical cancer.
    Fanning J; Ladd C; Hilgers RD
    Gynecol Oncol; 1995 Feb; 56(2):235-8. PubMed ID: 7896191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical 5-fluorouracil in the treatment of carcinoma in situ of the vulva.
    Carson TE; Hoskins WJ; Wurzel JF
    Obstet Gynecol; 1976 Jan; 47(1):59S-62S. PubMed ID: 1107909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of topical 5-fluorouracil in the treatment of genital condylomas.
    Krebs HB
    Obstet Gynecol Clin North Am; 1987 Jun; 14(2):559-68. PubMed ID: 3323965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of human papillomavirus-associated genital lesions in men.
    Krebs HB
    Obstet Gynecol; 1989 Mar; 73(3 Pt 1):312-6. PubMed ID: 2915856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a 1-week treatment with 0.5% topical fluorouracil on occurrence of actinic keratosis after cryosurgery: a randomized, vehicle-controlled clinical trial.
    Jorizzo J; Weiss J; Furst K; VandePol C; Levy SF
    Arch Dermatol; 2004 Jul; 140(7):813-6. PubMed ID: 15262691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal history of papillomavirus-induced dysplasia in the female lower genital tract.
    Vinokurova S; Wentzensen N; Einenkel J; Klaes R; Ziegert C; Melsheimer P; Sartor H; Horn LC; Höckel M; von Knebel Doeberitz M
    J Natl Cancer Inst; 2005 Dec; 97(24):1816-21. PubMed ID: 16368943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical 5-fluorouracil treatment of vaginal intraepithelial neoplasia.
    Caglar H; Hertzog RW; Hreshchyshyn MM
    Obstet Gynecol; 1981 Nov; 58(5):580-3. PubMed ID: 7301233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin/5-fluorouracil treatment of recurrent cervical carcinoma: a phase II study with long-term follow-up.
    Kaern J; Tropé C; Sundfoer K; Kristensen GB
    Gynecol Oncol; 1996 Mar; 60(3):387-92. PubMed ID: 8774643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subclinical cervicovaginal human papillomavirus infections associated with cervical condylomata and dysplasia. Treatment outcomes.
    Husseinzadeh N; Guoth JG; Jayawardena DS
    J Reprod Med; 1994 Oct; 39(10):777-80. PubMed ID: 7837123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.